Double-Blind Randomized Placebo-Controlled Trial of a Proprietary Full Hemp Flower Formulation for Long COVID

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
This is a double-blind, randomized, placebo-controlled single-center clinical trial to explore the safety and efficacy of a full cannabis flower formulation, rich in cannabinoids and terpenes formulation, Xltran Plus™ and Xltran™, both compared to placebo for the treatment of Long COVID patients with prolonged symptoms caused by COVID-19.
Epistemonikos ID: 54cd9ef41865b486570b21cc1fa2e1a60fd11a02
First added on: Jul 22, 2022